TWI367209B

A compound represented by the formula (1) wherein ring A is aryl optionally having substituent(s) and the like; ring B is arylene optionally having substituent(s) and the like; m=0-2; n=1-5; X is a bond and the like; Y is a bond and the like; and Z is hydrogen atom and the like or a pharmaceutically...

Full description

Saved in:
Bibliographic Details
Main Authors MATSUURA, MAMORU, HAMADA, MAIKO, TANAKA, MINORU, TAKEDA, SHUZO, KOBAYASHI, FUJIO, TANAKA, YOSHIHITO, HIGASHI, HIDEMITSU
Format Patent
LanguageChinese
Published 01.07.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A compound represented by the formula (1) wherein ring A is aryl optionally having substituent(s) and the like; ring B is arylene optionally having substituent(s) and the like; m=0-2; n=1-5; X is a bond and the like; Y is a bond and the like; and Z is hydrogen atom and the like or a pharmaceutically acceptable salt thereof, and a hydrate or solvate thereof have affinity for CCR3, and can be pharmaceutical products for the treatment and/or prophylaxis of immune or inflammatory diseases.
Bibliography:Application Number: TW200594130939